10 medical science liaison program experts
Managing MSL and field medical teams is the work these leaders share, in neurology, hematology, immunology, oncology and rare disease, at AstraZeneca, GSK, Novartis, AbbVie, Acadia Pharmaceuticals, Legend Biotech, argenx and Sobi. Seven currently hold head or executive director titles; the group can help a medical affairs team size its first MSL team for a launch, draw territories, or decide how field medical work is trained and measured.
Professionals to explore
Carol Heggie
LinkedInExperience: Executive Director - Head of Medical Science Liaison · Kyowa Kirin, Inc.- U.S.
$808 per 30-minute call
Carol Heggie has been Executive Director - Head of Medical Science Liaison at Kyowa Kirin, Inc.- U.S. since September 2024, shaping the strategic direction and operational management of MSL teams within Kyowa Kirin's Medical Affairs therapeutic areas, including standardization. Carol was Vice President Medical Excellence and Field Medical at Takeda (2019-2023) and Global Head of Medical Science Liaisons at Sanofi (2016-2019). Carol fits questions on standardizing MSL work across therapeutic areas.
Is this you? Claim your profile and get paid for calls.
Christina Reimers
LinkedInExperience: Head, National Director Field Medical- Hematology · Novartis
$943 per 30-minute call
Christina Reimers, PharmD, has held Head, National Director Field Medical- Hematology at Novartis since July 2023, leading the National Hematology MSL team and working with therapeutic area medical leadership, Strategy and Operations, Medical Directors and Scientific Communications. Christina's other Novartis titles are Executive Director MSLs -Malignant Hematology West (2021-2023), Scientific Strategy and Content Director CART (2021) and Oncology Medical Science Liaison-Director (2017-2021).
Is this you? Claim your profile and get paid for calls.
Dr. Michael Kemper
LinkedInExperience: Head of Medical Science Liaison Immunology & Cell Therapy · AstraZeneca
$1,010 per 30-minute call
Based in Germany, Dr. Michael Kemper has been Head of Medical Science Liaison Immunology & Cell Therapy at AstraZeneca since April 2025 and was Head of Medical Science Liaison Respiratory there (2022-2025). At UCB, Michael held Ecosystem Lead Immunology North West (Dermatology) (2021-2022) and Medical Science Liaison Manager (MSL) Immunology (Rheumatology Dermatology) (2015-2017), and was District Sales Manager Dermatology at Sanofi (2020-2021). Michael can compare MSL and sales leadership in immunology.
Is this you? Claim your profile and get paid for calls.
Jesse Lo Verme
LinkedInExperience: Executive Director, Medical Science Liaisons · Acadia Pharmaceuticals
$740 per 30-minute call
Jesse Lo Verme's Acadia Pharmaceuticals titles run from Sr. Medical Science Liaison (2015-2017) through Director (2017-2020) and Senior Director (2020-2022) to Executive Director, Medical Science Liaisons since March 2022. Jesse describes leading the field medical function at Acadia, including a neurology and psychiatry MSL team supporting Parkinson's and Alzheimer's disease and a rare disease MSL program in Rett Syndrome, and was a Medical Science Liaison at AbbVie (2009-2015).
Is this you? Claim your profile and get paid for calls.
Megan Murphy-Menezes
LinkedInExperience: Head, Myelofibrosis and Rare Disease MSL Team · GSK
$875 per 30-minute call
At GSK, Megan Murphy-Menezes has been Head, Myelofibrosis and Rare Disease MSL Team since March 2026, following Field Director, Oncology Medical Science Liaisons (2025-2026). Megan's other GSK titles include Interim Medical Affairs Lead, Heme (2023-2024), Director, Strategy and Operations Oncology Field Medical (2021-2023) and Field Director, MSL Team (Interim) (2022). The strategy and operations title make Megan a fit for questions on field medical strategy and operations in oncology.
Is this you? Claim your profile and get paid for calls.
Melanie Zacker
LinkedInExperience: National Field Director - Therapeutic Neurotoxins · AbbVie
$539 per 30-minute call
Melanie Zacker was Director, Medical Science Liaisons - Therapeutic Neurotoxins at AbbVie (2020-2024) and has been National Field Director - Therapeutic Neurotoxins there since February 2024, covering spasticity, movement disorders and urology. Melanie also held Director, Medical Science Liaisons - NeuroRehab and Urology (2018-2020) and Senior Medical Science Liaison (2015-2018) at Allergan. Melanie fits questions on MSL tactics for a neuroscience biologic.
Is this you? Claim your profile and get paid for calls.
Mike McGlynn
LinkedInExperience: MSL Director - Neurology · argenx
$539 per 30-minute call
MSL Director - Neurology at argenx since May 2024, Mike McGlynn was National Director, Precision Medicine Oncology-MSL Team at Bayer (2018-2024), Field Director, Northeast Multiple Sclerosis MSL Team at Biogen (2017-2018) and Specialty MSL Leader (National Field Director) and Medical Director at CSL (2013-2017). Mike describes national and regional MSL field director roles supporting marketed and pipeline products, which suits questions on national versus regional team design.
Is this you? Claim your profile and get paid for calls.
Stefanie Cribb
LinkedInExperience: Executive Director, Head of Medical Science Liaisons · Legend Biotech
$673 per 30-minute call
Stefanie Cribb, a Pharm.D., became Executive Director, Head of Medical Science Liaisons at Legend Biotech in June 2026, after Sr. Director Field Medical at PharmaEssentia (2023-2025). At Coherus Oncology, Stefanie held Ex. Dir., Medical Affairs - Head, Medical Science Liaisons (2021-2023), Sr. Director, Medical Affairs - Lead, Medical Science Liaisons (2020-2021) and Sr. Director, National Trainer- MSL Team and Managed Markets (2020). Stefanie fits questions on MSL training and managed markets liaison work.
Is this you? Claim your profile and get paid for calls.
Steven Casto
LinkedInExperience: Executive Director, Field Medical Affairs · uniQure; Former National Director, Medical Science Liaisons · Teva Pharmaceuticals
$606 per 30-minute call
Executive Director, Field Medical Affairs at uniQure since September 2025, Steven Casto lists gene therapy in rare disease and building MSL teams as the focus. At Teva Pharmaceuticals, Steven was Senior Director, CNS Field Medical Affairs (2023-2025), National Director, Medical Science Liaisons (2018-2023), Associate Director, Medical Science Liaisons (2016-2018) and Senior Medical Science Liaison (2014-2016). Steven can compare a CNS field team with one for gene therapy.
Is this you? Claim your profile and get paid for calls.
Tracey Caldarazzo
LinkedInExperience: Director, U.S. Medical Science Liaison Team · Sobi - Swedish Orphan Biovitrum AB (publ)
$471 per 30-minute call
Tracey Caldarazzo has been Director, U.S. Medical Science Liaison Team at Sobi - Swedish Orphan Biovitrum AB (publ) since May 2015 and describes being a senior leader, coach and trainer of MSLs. Tracey held Director, Medical & Scientific Affairs at Discovery Labs (2013-2015), Director, Medical Affairs at ZymoGenetics/BMS/The Medicine's Company (2007-2013) and Senior MSL at Nuvelo (2005-2007). Ask Tracey about coaching and training MSLs.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For setting up or restructuring an MSL function, start with the head and executive director titles: Carol Heggie, Stefanie Cribb, Jesse Lo Verme, Christina Reimers or Michael Kemper. Rare disease programs map to Megan Murphy-Menezes, Jesse Lo Verme (Rett Syndrome) and Steven Casto (gene therapy), while Mike McGlynn, Melanie Zacker and Tracey Caldarazzo hold national, U.S. or field director titles that fit questions on managing a field team.
Questions to take into the conversation
- 01How many medical science liaisons does a rare disease launch need compared with a neurology or oncology portfolio, and how should territories be drawn?
- 02Which MSL activity and quality measures hold up with medical affairs leadership without turning scientific exchange into a sales metric?
- 03What should an MSL onboarding and training program cover before new hires start meeting thought leaders in the field?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.